Welcome to LookChem.com Sign In|Join Free
  • or
1-(2,6-dichloro-benzyl)-1H-indol-6-ylamine is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

314752-14-2

Post Buying Request

314752-14-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

314752-14-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 314752-14-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,1,4,7,5 and 2 respectively; the second part has 2 digits, 1 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 314752-14:
(8*3)+(7*1)+(6*4)+(5*7)+(4*5)+(3*2)+(2*1)+(1*4)=122
122 % 10 = 2
So 314752-14-2 is a valid CAS Registry Number.

314752-14-2Downstream Products

314752-14-2Relevant academic research and scientific papers

High-affinity thrombin receptor (PAR-1) ligands: A new generation of indole-based peptide mimetic antagonists with a basic amine at the C-terminus

Zhang, Han-Cheng,White, Kimberly B.,McComsey, David F.,Addo, Michael F.,Andrade-Gordon, Patricia,Derian, Claudia K.,Oksenberg, Donna,Maryanoff, Bruce E.

, p. 2199 - 2203 (2007/10/03)

A new generation of indole-based peptide mimetics, bearing a basic amine at the C-terminus, was developed by the agency of two complementary, multistep, trityl resin-based approaches. Thus, we obtained several high-affinity thrombin receptor (PAR-1) ligands, such as 32 and 34. Compounds 32 and 34 were found to bind to PAR-1 with excellent affinity (IC50=25 and 35 nM, respectively) and to effectively block platelet aggregation induced by SFLLRN-NH2 (TRAP-6) and α-thrombin.

Novel indole peptidomimetics as thrombin receptor antagonists

-

Page 23, (2010/02/05)

The invention is directed to novel indole peptidomimetic compounds which are useful as thrombin receptor antagonists for the treatment of diseases associated with thrombosis, restenosis, hypertension, heart failure, arrhythmia, inflammation, angina, stroke, atherosclerosis, ischemic conditions, Angiogenesis related disorders, cancer, and neurodegenerative disorders. Pharmaceutical compositions comprising the substituted indole peptidomimetics of the present invention and methods of treating conditions mediated by the thrombin receptor are also disclosed.

Thrombin receptor (PAR-1) antagonists. Solid-phase synthesis of indole-based peptide mimetics by anchoring to a secondary amide

Zhang, Han-Cheng,McComsey, David F,White, Kimberly B,Addo, Michael F,Andrade-Gordon, Patricia,Derian, Claudia K,Oksenberg, Donna,Maryanoff, Bruce E

, p. 2105 - 2109 (2007/10/03)

A novel, 10-step, solid-phase method, based on a secondary amide linker, was developed to construct a diverse library of indole-based SFLLR peptide mimetics as thrombin receptor (protease-activated receptor 1, PAR-1) antagonists. The key steps include stepwise reductive alkylation, urea formation, and Mannich reaction. Screening of the library led to a quick development of the SAR and the significant improvement of PAR-1 activity.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 314752-14-2